title: Molgramostim to treat SS-sickle cell leg ulcers.
authors.forename: R C
authors.initials: RC
authors.lastname: Pieters
authors.forename: R A
authors.initials: RA
authors.lastname: Rojer
authors.forename: A W
authors.initials: AW
authors.lastname: Saleh
authors.forename: A E
authors.initials: AE
authors.lastname: Saleh
authors.forename: A J
authors.initials: AJ
authors.lastname: Duits
mesh_terms: D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000755:Anemia, Sickle Cell / Q000150:complications*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D007871:Leg Ulcer / Q000188:drug therapy* / Q000209:etiology; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects
chemical_list: D011994:Recombinant Proteins; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; C082430:molgramostim